Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

China Imidacloprid Market Production Trends and 2017 Forecasts in New Research Report at ReportsnReports.com
  • USA - English


News provided by

ReportsnReports.com

Aug 30, 2013, 22:30 ET

Share this article

Share toX

Share this article

Share toX

Dallas, Texas (PRWEB) August 31, 2013 -- As a major supplier of imidacloprid, China has many advantages in the production of imidacloprid, including efficient production technology, sufficient raw material supply and low production cost. About 50% of imidacloprid technical producers are located in Jiangsu Province. With the increasingly intense competition in the imidacloprid industry, while China's production of imidacloprid further concentrate in the future? What kind of enterprises will hold dominant positions in China's imidacloprid production?

China is a major imidacloprid export country, and over half of its imidacloprid output is exported to countries all over the world. The export value of imidacloprid in China has witnessed an increase of over 75% in 2012 compared with that in 2011. What are the reasons for this huge increase? Where are the imidacloprid products exported to? Will the export volume of imidacloprid in China continue enlarging in the future years? What is the trend of imidacloprid price in the future?

Purchase a report copy @ http://www.reportsnreports.com/Purchase.aspx?name=267696

In China, imidacloprid is mainly used in the control of rice plant hoppers and aphids. It is mainly applied to rice, wheat, cotton and vegetables. Domestic market of imidacloprid has seen a slow growth in recent years, and the market structure has some changes. What is the consumption structure on different crops and in different regions now? What will be the new growth point of imidacloprid in domestic market in the future?

This report can answer the above-mentioned questions and provide you a comprehensive insight of the imidacloprid industry in China. This report attaches importance to the following parts:

Update all the data related to imidacloprid industry from technical and formulations in China in 2008-H1 2013, including registration, supply, export, price and demand;

Identify the key players and potential producers of imidacloprid industry in China;

Emphasize consumption volume of the imidacloprid market in 2008-2012, as well as the consumption structure by crops and regions in 2012;

Figure out the development status and influencing factors including drivers and barriers;

Forecast imidacloprid industry development of supply, export and demand in 2013-2017;

Get a clear understanding of the future development trend, and identify China’s position in the imidacloprid industry from a global perspective;

Explore commercial opportunities of imidacloprid industry in China under the context of the new global economy situation;

Analyze substitutes for imidacloprid products in domestic market.

Executive Summary
With fast development in recent years, China's pesticide industry becomes more and more important in the global pesticide industry chain. Imidacloprid, as one of the major insecticides in China, also takes an important role in the global market. China is not only an imidacloprid producer that can guarantee its own agricultural production, but also an important imidacloprid exporter in the world. China has many advantages in the production of imidacloprid, including efficient production technology, stable raw material supply and low production cost, etc.

Production technology of imidacloprid
In China, there are mainly five pathways for the production of CCMP, an important intermediate of imidacloprid, namely DCPD route, morpholine route, 3-methylpyridine route, 2-amino-5-methylpyridine route and benzylamine route. At present, almost all domestic imidacloprid producers except for Jiangsu Yangnong adopt DCPD route in the production of imidacloprid and the rest routes are almost out of use in the production.

Currently DCPD route used for the commercial production of imidacloprid was innovated by Jiangsu Kwin in 2001, which brought in the experimental technology from Shenyang Research Institute of Chemical Industry in 1994.

Though the process of DCPD route is rather long, it has advantages of low production cost, better product quality and abundant supply of raw materials. It has been playing a dominant role in imidacloprid production in China in recent years. However, with the rapid development of technology, some domestic enterprises expect to improve CCMP synthesis by 3-methylpyridine route. In the future, if CCMP's isomers such as 2-chloro-3-methylpyridine can be isolated, the route will be popular thanks to its simple process.

Thanks to the large demand in overseas markets, China's output of imidacloprid will continuously increase CAGR in percent in 2013-2017.

Complete report available @ http://www.reportsnreports.com/reports/267696-production-and-market-of-imidacloprid-in-china-4th-edition.html

Browse more reports on Chemicals Market @ http://www.reportsnreports.com/market-research/chemicals/

About Us:

ReportsnReports.com is an online market research reports library of 350,000+ in-depth studies of over 5000 micro markets. We provide 24/7 online and offline support service to our customers.

Explore industry research reports focused on China at http://www.deepresearchreports.com

Priyank Tiwari, ReportsnReports.com, http://www.reportsnreports.com/, +1-888-391-5441, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.